Profil
Eric A.
Gulve is currently the Chairman of Drosmed LLC, President of BioGenerator, and Executive Vice President of BioSTL.
He previously served as Director of Neurolutions, Inc. and Cardialen, Inc. and as an Investor Director of Pulse Therapeutics, Inc. He also served as President of BioGenerator (Venture Capital).
Dr. Gulve holds a doctorate degree from Harvard University and an undergraduate degree from Occidental College.
Postes actifs de Eric Gulve
| Sociétés | Poste | Début |
|---|---|---|
Drosmed LLC
 Drosmed LLC Drugstore ChainsRetail Trade Drosmed LLC provides and develops drugs. It utilizes the fruit fly drosophila to take a whole animal approach to drug discovery for cancer metastasis and for diabetes-related diseases. The company was founded by Thomas John Baranski and Ross L. Cagan in 2006 and is headquartered in St. Louis, MO. | Président | 09/06/2011 |
BioSTL
 BioSTL Financial ConglomeratesFinance BioSTL is a non-profit organization based in St. Louis that has been working since 2001 to establish the region's innovation economy. The American company offers a range of programs that aim to solve important world challenges in fields such as agriculture, medicine, and healthcare. BioSTL has introduced several nationally acclaimed initiatives in startup creation and investment, strategic business attraction, physical environment, entrepreneur support, seed and venture capital, a diverse and inclusive workforce, and public policy. The non-profit company fosters collaborative efforts to advance innovation and entrepreneurship that build on St. Louis' world-class medical and plant biosciences. | President | 01/02/2014 |
BioGenerator
 BioGenerator Miscellaneous Commercial ServicesCommercial Services BioGenerator is a nonprofit investment arm of BioSTL that focuses on creating, growing, and investing in promising new bioscience companies and entrepreneurs. The non-profit company is based in St. Louis, MO and has subsidiaries in the United States. BioGenerator aims to advance St. Louis' prosperity by cultivating a thriving bioscience sector and building regional capacity to capitalize on St. Louis' world-class medical and plant biosciences. | President | 21/12/2022 |
Anciens postes connus de Eric Gulve
| Sociétés | Poste | Fin |
|---|---|---|
Neurolutions, Inc.
 Neurolutions, Inc. Medical SpecialtiesHealth Technology Neurolutions, Inc. develops revolutionary platform of devices, based on Brain Computer Interface (BCI) technology, which promise to restore function to patients who are disabled as a result of neurological injury. The company was founded by Eric Leuthhardt, Daniel J. Moran, and Gerwin Schalk on October 1, 2008 and is headquartered in St. Louis, MO. | Directeur/Membre du Conseil | 02/12/2019 |
Pulse Therapeutics, Inc.
 Pulse Therapeutics, Inc. Electronic Equipment/InstrumentsElectronic Technology Pulse Therapeutics, Inc. provides medical devices to destroy blood clots. Its devices help in treating the stroke, heart disease and other conditions. Its products include MED System which helps in dissolve blood clots. The company was founded by Francis M. Creighton and Rogers Ritter in 2008 and is headquartered in St. Louis, Mo. | Directeur/Membre du Conseil | 16/01/2019 |
Cardialen, Inc.
 Cardialen, Inc. Medical SpecialtiesHealth Technology Cardialen, Inc. develops medical devices. It offers pain-free cardio version therapy for atrial fibrillation (AF) using low-energy implantable atrial cardioverters. The firm develops and commercializes these as an independent specialist, to address major needs in atrial fibrillation management, achieve improved outcomes and reduce the risk of stroke, heart failure and high healthcare costs associated with atrial fibrillation. The company's products comprise implantable low-energy pain-free atrial cardioverters and cardiac leads and defibrillator equipment. Its products are used for the treatment of atrial and ventricular arrhythmias. Cardialen was founded in 2008 by D. Graeme Thomas, Randy H. Weiss and Igor R. Efimov and is headquartered in St. Louis, MO. | Directeur/Membre du Conseil | 01/07/2018 |
| GALERA THERAPEUTICS, INC. | Directeur/Membre du Conseil | - |
BioGenerator (Venture Capital)
 BioGenerator (Venture Capital) Investment ManagersFinance BioGenerator (Venture Capital) (BioGenerator) is a venture capital subsidiary of BioGenerator founded in 2003. The firm is headquartered in St. Louis, Missouri. | President | - |
Formation de Eric Gulve
| Harvard University | Doctorate Degree |
| Occidental College | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| GALERA THERAPEUTICS, INC. | Health Technology |
| Entreprise privées | 7 |
|---|---|
Neurolutions, Inc.
Neurolutions, Inc. Medical SpecialtiesHealth Technology Neurolutions, Inc. develops revolutionary platform of devices, based on Brain Computer Interface (BCI) technology, which promise to restore function to patients who are disabled as a result of neurological injury. The company was founded by Eric Leuthhardt, Daniel J. Moran, and Gerwin Schalk on October 1, 2008 and is headquartered in St. Louis, MO. | Health Technology |
Cardialen, Inc.
Cardialen, Inc. Medical SpecialtiesHealth Technology Cardialen, Inc. develops medical devices. It offers pain-free cardio version therapy for atrial fibrillation (AF) using low-energy implantable atrial cardioverters. The firm develops and commercializes these as an independent specialist, to address major needs in atrial fibrillation management, achieve improved outcomes and reduce the risk of stroke, heart failure and high healthcare costs associated with atrial fibrillation. The company's products comprise implantable low-energy pain-free atrial cardioverters and cardiac leads and defibrillator equipment. Its products are used for the treatment of atrial and ventricular arrhythmias. Cardialen was founded in 2008 by D. Graeme Thomas, Randy H. Weiss and Igor R. Efimov and is headquartered in St. Louis, MO. | Health Technology |
BioGenerator (Venture Capital)
BioGenerator (Venture Capital) Investment ManagersFinance BioGenerator (Venture Capital) (BioGenerator) is a venture capital subsidiary of BioGenerator founded in 2003. The firm is headquartered in St. Louis, Missouri. | Finance |
Pulse Therapeutics, Inc.
Pulse Therapeutics, Inc. Electronic Equipment/InstrumentsElectronic Technology Pulse Therapeutics, Inc. provides medical devices to destroy blood clots. Its devices help in treating the stroke, heart disease and other conditions. Its products include MED System which helps in dissolve blood clots. The company was founded by Francis M. Creighton and Rogers Ritter in 2008 and is headquartered in St. Louis, Mo. | Electronic Technology |
Drosmed LLC
Drosmed LLC Drugstore ChainsRetail Trade Drosmed LLC provides and develops drugs. It utilizes the fruit fly drosophila to take a whole animal approach to drug discovery for cancer metastasis and for diabetes-related diseases. The company was founded by Thomas John Baranski and Ross L. Cagan in 2006 and is headquartered in St. Louis, MO. | Retail Trade |
BioGenerator
BioGenerator Miscellaneous Commercial ServicesCommercial Services BioGenerator is a nonprofit investment arm of BioSTL that focuses on creating, growing, and investing in promising new bioscience companies and entrepreneurs. The non-profit company is based in St. Louis, MO and has subsidiaries in the United States. BioGenerator aims to advance St. Louis' prosperity by cultivating a thriving bioscience sector and building regional capacity to capitalize on St. Louis' world-class medical and plant biosciences. | Commercial Services |
BioSTL
BioSTL Financial ConglomeratesFinance BioSTL is a non-profit organization based in St. Louis that has been working since 2001 to establish the region's innovation economy. The American company offers a range of programs that aim to solve important world challenges in fields such as agriculture, medicine, and healthcare. BioSTL has introduced several nationally acclaimed initiatives in startup creation and investment, strategic business attraction, physical environment, entrepreneur support, seed and venture capital, a diverse and inclusive workforce, and public policy. The non-profit company fosters collaborative efforts to advance innovation and entrepreneurship that build on St. Louis' world-class medical and plant biosciences. | Finance |
